...
首页> 外文期刊>Integrative cancer therapies. >Fuzheng Qingjie Granules Inhibit Growth of Hepatoma Cells via Inducing Mitochondria-Mediated Apoptosis and Enhancing Immune Function
【24h】

Fuzheng Qingjie Granules Inhibit Growth of Hepatoma Cells via Inducing Mitochondria-Mediated Apoptosis and Enhancing Immune Function

机译:扶正庆杰颗粒通过诱导线粒体介导的细胞凋亡和增强免疫功能抑制肝癌细胞的生长

获取原文
           

摘要

Fuzheng Qingjie (FZQJ) granules, a compound Chinese medicine, have been used as an adjuvant therapy for alimentary tract cancers. However, the underlying anticancer mechanisms are still not well understood. In the present study, HepG2 cells were treated with FZQJ-containing serum. Cell proliferation was evaluated using MTT assay. Apoptosis was analyzed using a flow cytometer. Cell ultrastructure was observed under a transmission electron microscope. The mitochondrial membrane potential (Δψ) was examined with JC-1 dye. In H22 tumor–bearing mice, CD4+ T cells, CD8+ T cells, CD3+ T cells, and natural killer (NK) cells in peripheral blood were evaluated cytometrically. Interleukin (IL)-2 and tumor necrosis factor (TNF)-α levels were measured using radioimmunoassay.The mRNA levels of Bax and Bcl-2 were examined by reverse transcription–polymerase chain reaction. The protein levels of Bax, Bcl-2, cytochrome C, caspase 3 and 9, PARP, and CD69 were examined by Western blotting. The apoptotic cells in tissues were observed using TUNEL method. Alanine transaminase (ALT), aspartate transaminase (AST), blood urea nitrogen (BUN), and creatinine (CRE) were detected by an automatic biochemical analyzer. The results showed that FZQJ-containing serum remarkably inhibited proliferation of HepG2 cells in dose- and time-dependent manners, induced HepG2 cell apoptosis and caused a decrease of Δψ. Analysis of tumor tissue showed that FZQJ-induced apoptosis was accompanied by downregulation of Bcl-2 and upregulation of Bax, release of cytochrome c, activation of caspase 3 and 9, and cleavage of PARP. In addition, FZQJ increased the percentages of CD4+ T and NK cells, the ratio of CD4+/CD8+ T cells as well as the levels of serum TNF-α. FZQJ also increased CD69 expression in tumor tissue. No hepatorenal toxicity was observed in H22 tumor–bearing mice. These results indicated that FZQJ could inhibit the growth of hepatoma cells via regulating immune function and inducing mitochondria mediated apoptosis.
机译:福正清杰(FZQJ)颗粒,复合中药,已被用作消化道癌的佐剂疗法。然而,潜在的抗癌机制仍然没有很好地理解。在本研究中,HepG2细胞用含FZQJ的血清处理。使用MTT测定评估细胞增殖。使用流式细胞仪分析细胞凋亡。在透射电子显微镜下观察到细胞超微结构。用JC-1染料检查线粒体膜电位(ΔΣ)。在H22肿瘤小鼠中,CD4 + / sup> T细胞,CD8 + t细胞,CD3 + t细胞,天然杀伤剂(nk)细胞在外周血中进行细胞血量。使用放射免疫测定测量白细胞介素(IL)-2和肿瘤坏死因子(TNF)-α水平。通过逆转录 - 聚合酶链反应检查BAX和BCL-2的mRNA水平。通过Western印迹检查Bax,Bcl-2,细胞色素C,Caspase 3和9,PARP和CD69的蛋白质水平。使用TUNEL方法观察组织中的凋亡细胞。通过自动化生化分析仪检测丙氨酸转氨酶(ALT),天冬氨酸转氨酶(AST),血尿素氮(BUN)和肌酐(CRE)。结果表明,含FZQ血清的血清显着抑制了剂量和时间依赖的举止的HepG2细胞的增殖,诱导HepG2细胞凋亡并导致δψ的降低。肿瘤组织的分析表明,FZQJ诱导的细胞凋亡伴随着Bcl-2的下调和Bax的上调,细胞色素C的释放,胱天蛋白酶3和9的激活,并切割PARP。另外,FZQJ增加了CD4 + / sup> T和NK细胞的百分比,CD4 + / cd8 + t细胞的比例以及血清TNF-α水平。 FZQJ还增加了肿瘤组织中的CD69表达。在H22肿瘤携带的小鼠中观察到没有Hepatorenal毒性。这些结果表明,FZQJ可通过调节免疫功能和诱导线粒体介导的细胞凋亡来抑制肝癌细胞的生长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号